Arrowhead Pharmaceuticals (ARWR) Insider Trading & Ownership $18.71 +0.11 (+0.59%) (As of 11/20/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$54,990.00Number OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$7.59 M Get ARWR Insider Trade Alerts Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARWR Insider Buying and Selling by Quarter Ad Angel PublishingTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands on it. And Elon Musk has completely restructured Tesla to chase this opportunity. This is a once-in-a-lifetime opportunity that you don’t want to miss.Click here to get the details. Arrowhead Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32 5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.69 3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.00 3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.00 3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00 1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.65 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/12/2024James C HamiltonInsiderSell7,940$36.89$292,906.60 1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66 1/5/2024James C HamiltonInsiderSell32,143$35.18$1,130,790.74 1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08 1/5/2024Patrick O'brienCOOSell22,841$35.27$805,602.07 1/3/2024James C HamiltonInsiderSell6,300$32.19$202,797.00 1/3/2024Patrick O'brienCOOSell8,749$32.28$282,417.72 1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.52 12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.00 11/20/2023Martin Javier SanInsiderSell19,700$28.80$567,360.00 (Data available from 1/1/2013 forward) ARWR Insider Trading Activity - Frequently Asked Questions Who is on Arrowhead Pharmaceuticals's Insider Roster? The list of insiders at Arrowhead Pharmaceuticals includes Adeoye Y Olukotun, Christopher Richard Anzalone, Douglas B Given, Hongbo Lu, James C Hamilton, Kenneth Allen Myszkowski, Martin Javier San, Patrick O'brien, Tracie Oliver, Victoria Vakiener, and William D Waddill. Learn more on insiders at ARWR. What percentage of Arrowhead Pharmaceuticals stock is owned by insiders? 4.50% of Arrowhead Pharmaceuticals stock is owned by insiders. Learn more on ARWR's insider holdings. Which Arrowhead Pharmaceuticals insiders have been buying company stock? The following insider purchased ARWR shares in the last 24 months: Hongbo Lu ($54,990.00). How much insider buying is happening at Arrowhead Pharmaceuticals? Insiders have purchased a total of 2,000 ARWR shares in the last 24 months for a total of $54,990.00 bought. Which Arrowhead Pharmaceuticals insiders have been selling company stock? The following insiders have sold ARWR shares in the last 24 months: Adeoye Y Olukotun ($370,577.50), Christopher Richard Anzalone ($6,874,359.67), Douglas B Given ($405,185.16), James C Hamilton ($2,646,088.98), Kenneth Allen Myszkowski ($3,743,588.08), Martin Javier San ($1,152,165.00), Patrick O'brien ($2,319,644.79), Tracie Oliver ($552,622.07), Victoria Vakiener ($82,746.19), and William D Waddill ($96,000.00). How much insider selling is happening at Arrowhead Pharmaceuticals? Insiders have sold a total of 541,519 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $18,242,977.44 sold. Arrowhead Pharmaceuticals Key ExecutivesDr. Christopher R. Anzalone Ph.D. (Age 55)CEO, President & Director Compensation: $1.6MMr. Kenneth A. Myszkowski (Age 58)Chief Financial Officer Compensation: $834.34kMr. Patrick O'Brien J.D. (Age 60)PharmD, COO, General Counsel & Secretary Compensation: $835.14kDr. James C. Hamilton M.D. (Age 46)MBA, Chief of Discovery & Translational Medicine Compensation: $762.14kDr. Mark M. Davis Ph.D.Founder and Founder & Director of Insert Therapeutics Inc & CalandoDr. Vincent Anzalone CFAHead of Investor Relations & VPMr. Howard LovyDirector of CommunicationsDr. Bruce D. Given M.D. (Age 70)Chief Medical Scientist Compensation: $486.31kDr. Mark Seefeld (Age 70)Head of Toxicology & VP Ms. Tracie Oliver (Age 62)Chief Commercial Officer Compensation: $449.58k1 recent trades More Insider Trading Tools from MarketBeat Related Companies ACADIA Pharmaceuticals Insider Selling Amicus Therapeutics Insider Selling Perrigo Insider Selling Ionis Pharmaceuticals Insider Selling Jazz Pharmaceuticals Insider Selling Intra-Cellular Therapies Insider Selling Roivant Sciences Insider Selling Elanco Animal Health Insider Selling Blueprint Medicines Insider Selling Lantheus Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Selling Into 3 Rallies: Investors Should Do the OppositeInsiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking On This page (NASDAQ:ARWR) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ARWR Stock Alerts